Psychiatry
Bisher 105,99 €**
103,99 €
versandkostenfrei*

inkl. MwSt.
**Früherer Preis
Versandfertig in 2-4 Wochen
52 °P sammeln
    Broschiertes Buch

The purpose of the World Psychiatric Association is to coordinate the activities of its Member Societies on a world-wide scale and to advance enquiry into the etiology, pathology, and treatment of mental illness. To further this purpose, the Association organizes mono- or multi thematic Regional Symposia in different parts of the world twice a year, and World Congresses dealing with all individual fields of psychiatry once every five or six years. Between these meetings the continuation of the Association's scientific work is assured through the activities of its specialty sections, each…mehr

Produktbeschreibung
The purpose of the World Psychiatric Association is to coordinate the activities of its Member Societies on a world-wide scale and to advance enquiry into the etiology, pathology, and treatment of mental illness. To further this purpose, the Association organizes mono- or multi thematic Regional Symposia in different parts of the world twice a year, and World Congresses dealing with all individual fields of psychiatry once every five or six years. Between these meetings the continuation of the Association's scientific work is assured through the activities of its specialty sections, each covering an important field of psychiatry. The programs of the World Congresses reflect on the one hand the intention to present the coordinating functions of the Association and on the other to open a broad platform for a free exchange of views. Thus, the VII World Congress of Psychiatry, held in Vienna from July 11 to 16, 1983, was composed of two types of scientific events - those structured by the Association and those left to the initiative of the participants. The first type comprised Plenary Sessions, planned by the Scientific Program Committee, and Section Symposia, organized by the WPA sections; the second embraced Free Symposia, free papers, video sessions, and poster presentations prepa~ed by the participants. Altogether, 10 Plenary Sessions, 52 Section Symposia, and 105 Free Symposia took place, and 78 free papers and poster sessions and 10 video sessions were held.
  • Produktdetails
  • Verlag: Springer US / Springer, Berlin
  • Softcover reprint of the original 1st ed. 1985
  • Seitenzahl: 888
  • Erscheinungstermin: 4. Oktober 2011
  • Englisch
  • Abmessung: 254mm x 178mm x 47mm
  • Gewicht: 1634g
  • ISBN-13: 9781461294467
  • ISBN-10: 1461294460
  • Artikelnr.: 39561911
Inhaltsangabe
'Pharmaco EEG and Psychometry in Early Psychopharmacology.- Psychometry in Early Psychopharmacology.- On the Value of CNS, ANS and Behavorial Measures in Early Clinical Psychopharmacology.- The Multivariate Approach in Pharmaco-EEG and ERP Research.- Phase-IV Research in Psychiatry: Methodology and Objectives.- Phase-IV Research in Psychiatry: Research Objectives and Methodology.- Symptoms, Cognitions and Biology in General Practice Patients.- Studies in General Practice: Interpractice Differences.- The Private Practice Study Group as Phase-IV Research Tool.- The Outpatient Clinic as Phase-IV Research Tool.- Drug Monitoring in Psychiatric Hospitals.- Drug Strategies for Altering Cognitive Functions.- Psychopathology of Cognition.- The Cholinergic Basis of Memory - A Reappraisal.- Behavioral Effects of Vasopressin Treatment: Cognitive Implications.- The Relationship Between Depressive and Cognitive Disorders and Treatment with Nomifensine.- Cognitive Analysis of Neuropharmacological Treatments.- Predictors - New Antidepressants.- Is the TRH Test a Predictor and Parameter of the Therapeutic Response to Antidepressive Treatment?.- Treatment of Therapy-Resistant Depression.- Some General Remarks to the Problem of Therapy Resistant Depressions.- The Tyramine Pressor Test in Depressive Illness and Their Treatment with Antidepressants.- Biochemical Effects of Carbamazepine: Possible Mechanisms of Action in Affective and Seizure Disorders.- Atypical Depression Following Maternal Deprivation.- Treatment of Therapy-Resistant Depression with Drip Infusions.- Depression and its Treatment in the Problem Patient-Experiences with Bupropion, A New-Generation Antidepressant.- The Pharmacological Rationale for Bupropion.- Endogenous Depression and Response to Antidepressants.- Problems in the Treatment of the Chronic Depressive.- Plasma Monitoring of Antidepressants.- Anxiety Control Without Sedation in Depressed Patients Treated with Bupropion.- Weight Gain and Sexual Dysfunction During Treatment of Depression.- Early Onset of Action and Safety in Antidepressant Therapy with Trazodone - New Clinical Data.- Trazodone - A Distinctive Pharmacological Profile.- Trazodone and Mianserin in General Practice.- Trazodone-Induced Ventricular Arrhythmias: Fact or Artifact.- Acute Trazodone Poisoning: Clinical Signs and Plasma Concentrations.- Pirlindole in the Management of Depressed Patients in Clinical Practice.- The Novel Antidepressant Pirlindole: A Pharmacological Profile.- About the Central Effect of Pirlindole, A New Antidepressant.- The Pharmacokinetics of Pirlindole in Man.- Effect of Pirlindole on Endocrine Parameters in Healthy Man.- The Effect of Pirlindole on the Visually Evoked Cortical Potential (VECP) in Man.- Is There a Tyramine Potentiating Effect of Pirlindole?.- Studies of the Effects of Pirlindole on Sleep.- Placebo-Controlled Investigation on the Effects of Pirlindole on Sensorimotor Performance and Subjective Condition in Comparison to Imipramine and Under the Influence of Ethanol.- Pirlindole in Depression: An Open Clinical Study.- Long-Term Tolerance of Pirlindole in Patients with Chronic Schizophrenia and Accompanying Depressive Symptomatology.- Clinical Trials with the New Antidepressant Pirlindole in Patients with Depression and Various Psychiatric Diseases.- Dosage and Efficacy of the Antidepressant Pirlindole in 15 Female In-Patients with Depressive Syndrome.- Efficacy and Tolerance of Pirlindole in 20 Male In-Patients with Psychosis: Organic Brain Dysfunction and Accompanying Depression.- Pirlindole: Results of an Open Clinical Study in Out-Patients and of a Double-Blind Study Against Maprotiline.- Examining Pharmaco EEG-Based Predictions About the Antidepressant Action of Pirlindol by Double Blind Clinical Trials.- A Double Blind Comparison of Pirlindole with Amitriptyline and Imipramine.- A Double-Blind Comparative Study of